CLS - Company ID 0001030894
The table below shows CELESTICA INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $12.39B | $9.65B | $7.96B | $7.25B | - | - |
| Cost of revenue | $10.90B | $8.61B | $7.21B | $6.60B | - | - |
| Gross profit | $1.49B | $1.03B | $778.50M | $636.30M | $487.00M | $437.60M |
| R&D | $118.20M | $78.00M | $60.90M | $46.30M | $38.40M | $29.90M |
CELESTICA INC reported annual revenue of $12.39B for fiscal year 2025. That is up 28.5% from $9.65B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $259.90M |
| $293.50M |
| $303.20M |
| $267.30M |
| $245.10M |
| $230.70M |
| Operating income | $1.04B | $599.30M | $338.30M | $289.30M | - | - |
| Income tax | $150.70M | $104.20M | $61.60M | $59.00M | - | - |
| Net income | $832.50M | $428.00M | $244.40M | $180.10M | - | - |
| EPS (diluted) | $7.16 | $3.61 | $2.03 | $1.46 | - | - |